Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder

BJU International

Volumn 108, Issue 4, 2011, Pages 526-530

  Sfakianos, John P ^a   Shariat, Shahrokh F ^b   Favaretto, Ricardo Lima ^c   Rioja, Jorge ^c   Herr, Harry W ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BCG vaccine; bladder neoplasms; intravesical administration; local neoplasm recurrence; smoking

Indexed keywords

BCG VACCINE;

BCG VACCINATION; BLADDER MUSCLE; CANCER GRADING; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CARCINOMA IN SITU; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SMOKING; SMOKING CESSATION; SMOKING HABIT; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED; BCG VACCINE; CARCINOMA IN SITU; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 79951485685     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09874.x     Document Type: Review

References (20)

1. Jemal A, Siegel R, Ward E, et al,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
2. Prout GR Jr, Barton BA, Griffin PP, et al,. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J Urol 1992; 148: 1413-9
3. Pagano F, Bassi P, Galetti TP, et al,. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145: 45-50
4. Stabbert R, Schafer KH, Biefel C, et al,. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom 2003; 17: 2125-32 (Pubitemid 37098328)
5. Riedel K, Scherer G, Engl J, et al,. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 2006; 30: 187-95 (Pubitemid 44285276)
6. Skipper PL, Tannenbaum SR, Ross RK, et al,. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 503-7 (Pubitemid 36713643)
7. Samanic C, Kogevinas M, Dosemeci M, et al,. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006; 15: 1348-54 (Pubitemid 44125293)
8. Morrison AS, Buring JE, Verhoek WG, et al,. An international study of smoking and bladder cancer. J Urol 1984; 131: 650-4 (Pubitemid 14109607)
9. Burch JD, Rohan TE, Howe GR, et al,. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989; 44: 622-8 (Pubitemid 19258734)
10. Baris D, Karagas MR, Verrill C, et al,. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009; 101: 1553-61
11. Silverman DT, Devesa SS, Moore LL, et al. Bladder cancer. In, Schottenfeld D, Fraumeni JF, eds, Cancer Epidemiology and Prevention, New York, NY: Oxford University Press, 2006: 1101-27
12. Thompson IM, Peek M, Rodriguez FR,. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. J Urol 1987; 137: 401-3 (Pubitemid 17028264)
13. Shariat SF, Sfakianos JP, Droller MJ, et al,. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010; 105: 300-8
14. Aveyard P, Adab P, Cheng KK, et al,. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 2002; 90: 228-39 (Pubitemid 34989068)
15. Alexandroff AB, Jackson AM, O'Donnell MA, et al,. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999; 353: 1689-94 (Pubitemid 29224536)
16. Wiley SR, Scholley K, Smolak PJ, et al,. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-82 (Pubitemid 26091143)
17. Ludwig AT, Moore JM, Luo Y, et al,. Tumor necrosis factor-related apoptosis-inducing ligans: a novel mechanism for bacillus Calmatte-Guerin- induced antitumor activity. Cancer Res 2004; 64: 3386-90 (Pubitemid 38657909)
18. Mian MF, Pek EA, Mossman KL, Stampfli MR, Ashkar AA,. Exposure to cigarette smoke suppresses IL-15 generation and its regulatory NK cell functions in polyI:C-augmented human PBMCs. Mol Immunol 2009; 46: 3108-116
19. Sopori M,. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2: 372-7 (Pubitemid 37328760)
20. Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR,. Late age (85 years or older) peak incidence of bladder cancer. J Urol 2008; 179: 1302-5